Doctor profile · Federal record

Dr. Richard Gomendoza, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Endocrinology, Diabetes & Metabolism Physician · Salina, KS

  • NPI 1841255734
  • Accepts Medicare
  • MIPS 77.5 / 100 · 2023
  • 33 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2090 S. Ohio St., Suite 3W
Salina, KS 67401
(785) 309-2323
fax (785) 309-2331

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
March 11, 2020
Year of graduation
1993 — 33 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
Kansas #0428513 · Missouri #2015033468
Medicaid
KS #200269770D

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1841255734. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,076
Distinct HCPCS
9
Medicare allowed
$191,610
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 2,580 27 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 561 358 $119
99213 Established patient office or other outpatient visit, 20-29 minutes 354 267 $84
83036 Hemoglobin a1c level 207 116 $9
99204 New patient office or other outpatient visit, 45-59 minutes 153 153 $156
96372 Injection of drug or substance under skin or into muscle 119 40 $13
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 69 53 $21
99205 New patient office or other outpatient visit, 60-74 minutes 17 17 $208
99215 Established patient office or other outpatient visit, 40-54 minutes 16 15 $160

In context: peer comparison

Among 1 peers in this city , average services per provider: 452. This provider delivers 9.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,976
Transactions
99
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Corcept Therapeutics 9 $234.47
Lilly USA, LLC 13 $227.62
ABBVIE INC. 18 $218.82
Boehringer Ingelheim Pharmaceuticals, Inc. 15 $184.46
Dexcom, Inc. 7 $153.57
Novo Nordisk Inc 12 $135.77
CeQur Corporation 1 $121.81
SANOFI-AVENTIS U.S. LLC 5 $119.02
Insulet Corporation 6 $103.98
Ascensia Diabetes Care Us Inc. 2 $77.46
RECORDATI_RARE_DISEASES_INC. 3 $67.25
Amneal Pharmaceuticals LLC 2 $56.39
Nevro Corp. 2 $47.51
Tandem Diabetes Care, Inc. 2 $41.64
Medtronic, Inc. 2 $35.10

By nature of payment

Food and Beverage
$1,976

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,511
Patients
523
Total drug cost
$590,482
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 719 150 $8,497
Synthroid (Levothyroxine Sodium) Brand 343 72 $26,413
Methimazole Generic 264 59 $3,328
Hydrocortisone Generic 157 23 $6,205
Metformin Hcl Er (Metformin Hcl) Brand 116 31 $1,392
Ozempic (Semaglutide) Brand 111 26 $135,735
Trulicity (Dulaglutide) Brand 109 21 $146,783
Potassium Chloride Generic 103 19 $5,114
Jardiance (Empagliflozin) Brand 102 18 $104,895
Novolog Flexpen (Insulin Aspart) Brand 95 24 $70,114

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Richard Gomendoza's medical specialty?
Dr. Richard Gomendoza practices Endocrinology, Diabetes & Metabolism Physician in Salina, KS.
Where does Dr. Richard Gomendoza practice?
Dr. Richard Gomendoza practices at 2090 S. Ohio St., Salina, KS 67401. Office phone: 7853092323.
What is Dr. Richard Gomendoza's NPI?
Dr. Richard Gomendoza's National Provider Identifier (NPI) is 1841255734, issued by NPPES.
Does Dr. Richard Gomendoza accept Medicare assignment?
Yes. Dr. Richard Gomendoza accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Richard Gomendoza commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.